{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:54:56Z","timestamp":1793904896889,"version":"4.8.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10753-022-01725-x","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T19:02:52Z","timestamp":1660244572000},"page":"35-46","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["NLRP3 Inflammasome in Atherosclerosis: Putting Out the Fire of Inflammation"],"prefix":"10.1007","volume":"46","author":[{"given":"Bo-Zong","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Cheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Rui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Ren","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"issue":"2","key":"1725_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1210\/endrev\/bnab027","volume":"43","author":"ENC Manoogian","year":"2022","unstructured":"Manoogian, E.N.C., L.S. Chow, P.R. Taub, B. Laferrere, and S. Panda. 2022. Time-restricted Eating for the Prevention and Management of Metabolic Diseases. Endocrine Reviews 43 (2): 405\u2013436. https:\/\/doi.org\/10.1210\/endrev\/bnab027.","journal-title":"Endocrine Reviews"},{"key":"1725_CR2","doi-asserted-by":"publisher","unstructured":"Fahed, G., L. Aoun, M. Bou. Zerdan, S. Allam, M. Bou Zerdan, Y. Bouferraa, and H.I. Assi. 2022. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. International Journal of Molecular Sciences\u00a023 (2). https:\/\/doi.org\/10.3390\/ijms23020786.","DOI":"10.3390\/ijms23020786"},{"key":"1725_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101409","volume":"55","author":"JR Colca","year":"2022","unstructured":"Colca, J.R., and P.E. Scherer. 2022. The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease. Molecular Metabolism 55: 101409. https:\/\/doi.org\/10.1016\/j.molmet.2021.101409.","journal-title":"Molecular Metabolism"},{"key":"1725_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154461","volume":"116","author":"EK Valanti","year":"2021","unstructured":"Valanti, E.K., K. Dalakoura-Karagkouni, G. Siasos, D. Kardassis, A.G. Eliopoulos, and D. Sanoudou. 2021. Advances in biological therapies for dyslipidemias and atherosclerosis. Metabolism 116: 154461. https:\/\/doi.org\/10.1016\/j.metabol.2020.154461.","journal-title":"Metabolism"},{"issue":"5","key":"1725_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41584-021-00593-3","volume":"17","author":"F Atzeni","year":"2021","unstructured":"Atzeni, F., J. Rodriguez-Carrio, C.D. Popa, M.T. Nurmohamed, G. Szucs, and Z. Szekanecz. 2021. Cardiovascular effects of approved drugs for rheumatoid arthritis. Nature Reviews Rheumatology 17 (5): 270\u2013290. https:\/\/doi.org\/10.1038\/s41584-021-00593-3.","journal-title":"Nature Reviews Rheumatology"},{"key":"1725_CR6","doi-asserted-by":"publisher","unstructured":"Jebari-Benslaiman, S., U. Galicia-Garcia, A. Larrea-Sebal, J.R. Olaetxea, I. Alloza, K. Vandenbroeck, A. Benito-Vicente, and C. Martin. 2022. Pathophysiology of Atherosclerosis. International Journal of Molecular Sciences 23 (6). https:\/\/doi.org\/10.3390\/ijms23063346.","DOI":"10.3390\/ijms23063346"},{"issue":"4","key":"1725_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","volume":"22","author":"P Roy","year":"2022","unstructured":"Roy, P., M. Orecchioni, and K. Ley. 2022. How the immune system shapes atherosclerosis: Roles of innate and adaptive immunity. Nature Reviews Immunology 22 (4): 251\u2013265. https:\/\/doi.org\/10.1038\/s41577-021-00584-1.","journal-title":"Nature Reviews Immunology"},{"key":"1725_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.809955","volume":"9","author":"L Lin","year":"2021","unstructured":"Lin, L., M.X. Zhang, L. Zhang, D. Zhang, C. Li, and Y.L. Li. 2021. Autophagy, pyroptosis, and ferroptosis: New regulatory mechanisms for atherosclerosis. Frontiers in Cell and Developmental Biology 9: 809955. https:\/\/doi.org\/10.3389\/fcell.2021.809955.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"3","key":"1725_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/pin.13202","volume":"72","author":"J Fan","year":"2022","unstructured":"Fan, J., and T. Watanabe. 2022. Atherosclerosis: Known and unknown. Pathology International 72 (3): 151\u2013160. https:\/\/doi.org\/10.1111\/pin.13202.","journal-title":"Pathology International"},{"issue":"7855","key":"1725_CR10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby, P. 2021. The changing landscape of atherosclerosis. Nature 592 (7855): 524\u2013533. https:\/\/doi.org\/10.1038\/s41586-021-03392-8.","journal-title":"Nature"},{"issue":"12","key":"1725_CR11","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1042\/CS20180306","volume":"132","author":"GR Geovanini","year":"2018","unstructured":"Geovanini, G.R., and P. Libby. 2018. Atherosclerosis and inflammation: Overview and updates. Clinical Science (London, England) 132 (12): 1243\u20131252. https:\/\/doi.org\/10.1042\/CS20180306.","journal-title":"Clinical Science (London, England)"},{"issue":"2","key":"1725_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","volume":"124","author":"D Wolf","year":"2019","unstructured":"Wolf, D., and K. Ley. 2019. Immunity and Inflammation in Atherosclerosis. Circulation Research 124 (2): 315\u2013327. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313591.","journal-title":"Circulation Research"},{"issue":"8","key":"1725_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","volume":"20","author":"O Soehnlein","year":"2021","unstructured":"Soehnlein, O., and P. Libby. 2021. Targeting inflammation in atherosclerosis - from experimental insights to the clinic. Nature Reviews. Drug Discovery 20 (8): 589\u2013610. https:\/\/doi.org\/10.1038\/s41573-021-00198-1.","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"1","key":"1725_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/CIRCRESAHA.121.319822","volume":"130","author":"AC Doran","year":"2022","unstructured":"Doran, A.C. 2022. Inflammation resolution: Implications for atherosclerosis. Circulation Research 130 (1): 130\u2013148. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.319822.","journal-title":"Circulation Research"},{"issue":"1","key":"1725_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","volume":"7","author":"P Kong","year":"2022","unstructured":"Kong, P., Z.Y. Cui, X.F. Huang, D.D. Zhang, R.J. Guo, and M. Han. 2022. Inflammation and atherosclerosis: Signaling pathways and therapeutic intervention. Signal Transduction and Targeted Therapy 7 (1): 131. https:\/\/doi.org\/10.1038\/s41392-022-00955-7.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"1725_CR16","doi-asserted-by":"publisher","unstructured":"Ley, K. 2021. Inflammation and Atherosclerosis. Cells 10 (5). https:\/\/doi.org\/10.3390\/cells10051197.","DOI":"10.3390\/cells10051197"},{"key":"1725_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.molimm.2022.03.005","volume":"145","author":"SM Yamada","year":"2022","unstructured":"Yamada, S.M., and A. Pontillo. 2022. The genetics behind inflammasome regulation. Molecular Immunology 145: 27\u201342. https:\/\/doi.org\/10.1016\/j.molimm.2022.03.005.","journal-title":"Molecular Immunology"},{"issue":"5","key":"1725_CR18","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"BR Sharma","year":"2021","unstructured":"Sharma, B.R., and T.D. Kanneganti. 2021. NLRP3 inflammasome in cancer and metabolic diseases. Nature Immunology 22 (5): 550\u2013559. https:\/\/doi.org\/10.1038\/s41590-021-00886-5.","journal-title":"Nature Immunology"},{"issue":"11","key":"1725_CR19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.tcb.2021.06.010","volume":"31","author":"A Pandey","year":"2021","unstructured":"Pandey, A., C. Shen, S. Feng, and S.M. Man. 2021. Cell biology of inflammasome activation. Trends in Cell Biology 31 (11): 924\u2013939. https:\/\/doi.org\/10.1016\/j.tcb.2021.06.010.","journal-title":"Trends in Cell Biology"},{"key":"1725_CR20","doi-asserted-by":"publisher","unstructured":"Kelley, N., D. Jeltema, Y. Duan, and Y. He. 2019. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. International Journal of Molecular Sciences 20 (13). https:\/\/doi.org\/10.3390\/ijms20133328.","DOI":"10.3390\/ijms20133328"},{"key":"1725_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108719","volume":"108","author":"Y Qiu","year":"2022","unstructured":"Qiu, Y., Y. Huang, M. Chen, Y. Yang, X. Li, and W. Zhang. 2022. Mitochondrial DNA in NLRP3 inflammasome activation. International Immunopharmacology 108: 108719. https:\/\/doi.org\/10.1016\/j.intimp.2022.108719.","journal-title":"International Immunopharmacology"},{"issue":"1","key":"1725_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08916934.2021.1995860","volume":"55","author":"R Kong","year":"2022","unstructured":"Kong, R., L. Sun, H. Li, and D. Wang. 2022. The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease. Autoimmunity 55 (1): 1\u20137. https:\/\/doi.org\/10.1080\/08916934.2021.1995860.","journal-title":"Autoimmunity"},{"key":"1725_CR23","doi-asserted-by":"publisher","unstructured":"Paget, C., E. Doz-Deblauwe, N. Winter, and B. Briard. 2022. Specific NLRP3 inflammasome assembling and regulation in neutrophils: relevance in inflammatory and infectious diseases. Cells 11 (7). https:\/\/doi.org\/10.3390\/cells11071188.","DOI":"10.3390\/cells11071188"},{"issue":"7904","key":"1725_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41586-022-04467-w","volume":"604","author":"M Hochheiser IV","year":"2022","unstructured":"Hochheiser, M., IV., G Hagelueken Pilsl, J. Moecking, M. Marleaux, R. Brinkschulte, E. Latz, C. Engel, and M. Geyer. 2022. Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3. Nature 604 (7904): 184\u2013189. https:\/\/doi.org\/10.1038\/s41586-022-04467-w.","journal-title":"Nature"},{"issue":"9873","key":"1725_CR25","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(13)60598-X","volume":"381","author":"RC Thompson","year":"2013","unstructured":"Thompson, R.C., A.H. Allam, G.P. Lombardi, L.S. Wann, M.L. Sutherland, J.D. Sutherland, M.A. Soliman, et al. 2013. Atherosclerosis across 4000 years of human history: The Horus study of four ancient populations. Lancet 381 (9873): 1211\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(13)60598-X.","journal-title":"Lancet"},{"key":"1725_CR26","doi-asserted-by":"publisher","unstructured":"Chu, C.S., S.H. Law, D. Lenzen, Y.H. Tan, S.F. Weng, E. Ito, J.C. Wu, C.H. Chen, H.C. Chan, and L.Y. Ke. 2020. Clinical significance of electronegative low-density lipoprotein cholesterol in atherothrombosis. Biomedicines 8 (8). https:\/\/doi.org\/10.3390\/biomedicines8080254.","DOI":"10.3390\/biomedicines8080254"},{"issue":"7407","key":"1725_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nature11260","volume":"487","author":"P Dutta","year":"2012","unstructured":"Dutta, P., G. Courties, Y. Wei, F. Leuschner, R. Gorbatov, C.S. Robbins, Y. Iwamoto, et al. 2012. Myocardial infarction accelerates atherosclerosis. Nature 487 (7407): 325\u2013329. https:\/\/doi.org\/10.1038\/nature11260.","journal-title":"Nature"},{"issue":"8","key":"1725_CR28","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1161\/ATVBAHA.119.312578","volume":"39","author":"J Palasubramaniam","year":"2019","unstructured":"Palasubramaniam, J., X. Wang, and K. Peter. 2019. Myocardial infarction-from atherosclerosis to thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology 39 (8): e176\u2013e185. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312578.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"13","key":"1725_CR29","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1093\/cvr\/cvab285","volume":"117","author":"F Porsch","year":"2021","unstructured":"Porsch, F., Z. Mallat, and C.J. Binder. 2021. Humoral immunity in atherosclerosis and myocardial infarction: From B cells to antibodies. Cardiovascular Research 117 (13): 2544\u20132562. https:\/\/doi.org\/10.1093\/cvr\/cvab285.","journal-title":"Cardiovascular Research"},{"issue":"46","key":"1725_CR30","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1093\/eurheartj\/ehaa849","volume":"41","author":"B Chandrasekar","year":"2020","unstructured":"Chandrasekar, B., and M. Alanbaei. 2020. Intracoronary imaging identifies plaque rupture underlying left main thrombosis in acute myocardial infarction without angiographically evident atherosclerosis. European Heart Journal 41 (46): 4448. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa849.","journal-title":"European Heart Journal"},{"issue":"2","key":"1725_CR31","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ccd.29179","volume":"97","author":"D Tedeschi","year":"2021","unstructured":"Tedeschi, D., A. Rizzi, S. Biscaglia, and C. Tumscitz. 2021. Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19. Catheterization and Cardiovascular Interventions 97 (2): 272\u2013277. https:\/\/doi.org\/10.1002\/ccd.29179.","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"1","key":"1725_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.33963\/KP.15090","volume":"78","author":"L Loczi","year":"2020","unstructured":"Loczi, L., J. Kappelmayer, T. Tarr, and Z. Bagoly. 2020. Antiphospholipid syndrome and the risk of myocardial infarction: Current evidence and uncertainties. Kardiologia Polska 78 (1): 6\u201314. https:\/\/doi.org\/10.33963\/KP.15090.","journal-title":"Kardiologia Polska"},{"issue":"2","key":"1725_CR33","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/aps.2015.87","volume":"37","author":"BZ Shao","year":"2016","unstructured":"Shao, B.Z., B.Z. Han, Y.X. Zeng, D.F. Su, and C. Liu. 2016. The roles of macrophage autophagy in atherosclerosis. Acta Pharmacologica Sinica 37 (2): 150\u2013156. https:\/\/doi.org\/10.1038\/aps.2015.87.","journal-title":"Acta Pharmacologica Sinica"},{"key":"1725_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejphar.2017.05.010","volume":"816","author":"B Emini Veseli","year":"2017","unstructured":"Emini Veseli, B., P. Perrotta, G.R.A. De Meyer, L. Roth, C. Van der Donckt, W. Martinet, and G.R.Y. De Meyer. 2017. Animal models of atherosclerosis. European Journal of Pharmacology 816: 3\u201313. https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.010.","journal-title":"European Journal of Pharmacology"},{"key":"1725_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-981-15-4272-5_18","volume":"1207","author":"J Miao","year":"2020","unstructured":"Miao, J., X. Zang, X. Cui, and J. Zhang. 2020. Autophagy, Hyperlipidemia, and Atherosclerosis. Advances in Experimental Medicine and Biology 1207: 237\u2013264. https:\/\/doi.org\/10.1007\/978-981-15-4272-5_18.","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"2","key":"1725_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41565-019-0599-3","volume":"15","author":"G Fredman","year":"2020","unstructured":"Fredman, G. 2020. Devouring atherosclerotic plaques. Nature Nanotechnology 15 (2): 84\u201385. https:\/\/doi.org\/10.1038\/s41565-019-0599-3.","journal-title":"Nature Nanotechnology"},{"key":"1725_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.atherosclerosis.2020.05.017","volume":"306","author":"H Jinnouchi","year":"2020","unstructured":"Jinnouchi, H., Y. Sato, A. Sakamoto, A. Cornelissen, M. Mori, R. Kawakami, N.V. Gadhoke, F.D. Kolodgie, R. Virmani, and A.V. Finn. 2020. Calcium deposition within coronary atherosclerotic lesion: Implications for plaque stability. Atherosclerosis 306: 85\u201395. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.05.017.","journal-title":"Atherosclerosis"},{"key":"1725_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/bs.apcsb.2019.11.002","volume":"120","author":"A Munjal","year":"2020","unstructured":"Munjal, A., and R. Khandia. 2020. Atherosclerosis: Orchestrating cells and biomolecules involved in its activation and inhibition. Advances in Protein Chemistry and Structural Biology 120: 85\u2013122. https:\/\/doi.org\/10.1016\/bs.apcsb.2019.11.002.","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"key":"1725_CR39","unstructured":"Linton, M.R.F., P.G. Yancey, S.S. Davies, W.G. Jerome, E.F. Linton, W.L. Song, A.C. Doran, and K.C. Vickers. 2000. The Role of Lipids and Lipoproteins in Atherosclerosis. In Endotext, eds. K. R. Feingold, and B. Anawalt, and A. Boyce, and G. Chrousos, and W. W. de Herder, and K. Dhatariya, and K. Dungan et al. South Dartmouth (MA)."},{"issue":"9","key":"1725_CR40","doi-asserted-by":"publisher","first-page":"6154","DOI":"10.1002\/jcp.30300","volume":"236","author":"J Li","year":"2021","unstructured":"Li, J., Q. Meng, Y. Fu, X. Yu, T. Ji, Y. Chao, Q. Chen, Y. Li, and H. Bian. 2021. Novel insights: Dynamic foam cells derived from the macrophage in atherosclerosis. Journal of Cellular Physiology 236 (9): 6154\u20136167. https:\/\/doi.org\/10.1002\/jcp.30300.","journal-title":"Journal of Cellular Physiology"},{"issue":"4","key":"1725_CR41","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/CIRCRESAHA.115.306256","volume":"118","author":"I Tabas","year":"2016","unstructured":"Tabas, I., and K.E. Bornfeldt. 2016. Macrophage phenotype and function in different stages of atherosclerosis. Circulation Research 118 (4): 653\u2013667. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306256.","journal-title":"Circulation Research"},{"key":"1725_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.vph.2018.08.002","volume":"112","author":"EM Maguire","year":"2019","unstructured":"Maguire, E.M., S.W.A. Pearce, and Q. Xiao. 2019. Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease. Vascular Pharmacology 112: 54\u201371. https:\/\/doi.org\/10.1016\/j.vph.2018.08.002.","journal-title":"Vascular Pharmacology"},{"key":"1725_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-3-319-57613-8_4","volume":"1003","author":"C Sturtzel","year":"2017","unstructured":"Sturtzel, C. 2017. Endothelial Cells. Advances in Experimental Medicine and Biology 1003: 71\u201391. https:\/\/doi.org\/10.1007\/978-3-319-57613-8_4.","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"5","key":"1725_CR44","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/jat.4115","volume":"41","author":"H Liang","year":"2021","unstructured":"Liang, H., R. Yue, C. Zhou, M. Liu, X. Yu, S. Lu, J. Zeng, Z. Yu, Z. Zhou, and H. Hu. 2021. Cadmium exposure induces endothelial dysfunction via disturbing lipid metabolism in human microvascular endothelial cells. Journal of Applied Toxicology 41 (5): 775\u2013788. https:\/\/doi.org\/10.1002\/jat.4115.","journal-title":"Journal of Applied Toxicology"},{"issue":"11\u201312","key":"1725_CR45","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/lipd.12195","volume":"54","author":"Y Ding","year":"2019","unstructured":"Ding, Y., Y. Feng, W. Zhu, Y. Zou, Y. Xie, F. Wang, C.F. Liu, Y. Zhang, and H. Liu. 2019. [Gly14]-Humanin prevents lipid deposition and endothelial cell apoptosis in a lectin-like oxidized low-density lipoprotein receptor-1-dependent manner. Lipids 54 (11\u201312): 697\u2013705. https:\/\/doi.org\/10.1002\/lipd.12195.","journal-title":"Lipids"},{"key":"1725_CR46","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cca.2019.10.034","volume":"501","author":"S Yang","year":"2020","unstructured":"Yang, S., H.Q. Yuan, Y.M. Hao, Z. Ren, S.L. Qu, L.S. Liu, D.H. Wei, Z.H. Tang, J.F. Zhang, and Z.S. Jiang. 2020. Macrophage polarization in atherosclerosis. Clinica Chimica Acta 501: 142\u2013146. https:\/\/doi.org\/10.1016\/j.cca.2019.10.034.","journal-title":"Clinica Chimica Acta"},{"issue":"3","key":"1725_CR47","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41423-021-00791-9","volume":"19","author":"SK Wculek","year":"2022","unstructured":"Wculek, S.K., G. Dunphy, I. Heras-Murillo, A. Mastrangelo, and D. Sancho. 2022. Metabolism of tissue macrophages in homeostasis and pathology. Cellular & Molecular Immunology 19 (3): 384\u2013408. https:\/\/doi.org\/10.1038\/s41423-021-00791-9.","journal-title":"Cellular & Molecular Immunology"},{"key":"1725_CR48","doi-asserted-by":"publisher","unstructured":"Zhang, X., J.G. McDonald, B. Aryal, A. Canfran-Duque, E.L. Goldberg, E. Araldi, W. Ding, et al.\u00a02021. Desmosterol suppresses macrophage inflammasome activation and protects against vascular inflammation and atherosclerosis. Proceedings of the National Academy of Sciences USA 118 (47). https:\/\/doi.org\/10.1073\/pnas.2107682118.","DOI":"10.1073\/pnas.2107682118"},{"key":"1725_CR49","doi-asserted-by":"publisher","first-page":"15750","DOI":"10.1038\/ncomms15750","volume":"8","author":"I Sergin","year":"2017","unstructured":"Sergin, I., T.D. Evans, X. Zhang, S. Bhattacharya, C.J. Stokes, E. Song, S. Ali, et al. 2017. Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis. Nature Communications 8: 15750. https:\/\/doi.org\/10.1038\/ncomms15750.","journal-title":"Nature Communications"},{"issue":"5","key":"1725_CR50","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1016\/j.apsb.2021.12.014","volume":"12","author":"X Li","year":"2022","unstructured":"Li, X., R. Zhu, H. Jiang, Q. Yin, J. Gu, J. Chen, X. Ji, et al. 2022. Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB-P300-BRD4 axis. Acta Pharm Sin B 12 (5): 2280\u20132299. https:\/\/doi.org\/10.1016\/j.apsb.2021.12.014.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"1725_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/clinchem\/hvaa275","volume":"67","author":"P Libby","year":"2021","unstructured":"Libby, P. 2021. Inflammation in atherosclerosis-no longer a theory. Clinical Chemistry 67 (1): 131\u2013142. https:\/\/doi.org\/10.1093\/clinchem\/hvaa275.","journal-title":"Clinical Chemistry"},{"issue":"3","key":"1725_CR52","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/eji.201242687","volume":"43","author":"AC Tissot","year":"2013","unstructured":"Tissot, A.C., G. Spohn, G.T. Jennings, A. Shamshiev, M.O. Kurrer, R. Windak, M. Meier, et al. 2013. A VLP-based vaccine against interleukin-1alpha protects mice from atherosclerosis. European Journal of Immunology 43 (3): 716\u2013722. https:\/\/doi.org\/10.1002\/eji.201242687.","journal-title":"European Journal of Immunology"},{"issue":"1","key":"1725_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113025","volume":"412","author":"F Xu","year":"2022","unstructured":"Xu, F., J. Zhang, X. Zhou, and H. Hao. 2022. Lipoxin A4 and its analog attenuate high fat diet-induced atherosclerosis via Keap1\/Nrf2 pathway. Experimental Cell Research 412 (1): 113025. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113025.","journal-title":"Experimental Cell Research"},{"key":"1725_CR54","doi-asserted-by":"publisher","unstructured":"Pieczynska, M.D., Y. Yang, S. Petrykowski, O.K. Horbanczuk, A.G. Atanasov, and J.O. Horbanczuk. 2020. Gut microbiota and its metabolites in atherosclerosis development. Molecules 25 (3). https:\/\/doi.org\/10.3390\/molecules25030594.","DOI":"10.3390\/molecules25030594"},{"key":"1725_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.760980","volume":"9","author":"H Yang","year":"2021","unstructured":"Yang, H., H. Li, W. Chen, Z. Mei, Y. Yuan, X. Wang, L. Chu, et al. 2021. Therapeutic effect of Schistosoma japonicum cystatin on atherosclerotic renal damage. Frontiers in Cell and Developmental Biology 9: 760980. https:\/\/doi.org\/10.3389\/fcell.2021.760980.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"2","key":"1725_CR56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/FJC.0000000000000642","volume":"73","author":"J Ma","year":"2019","unstructured":"Ma, J., D. Zhao, X. Wang, C. Ma, K. Feng, S. Zhang, Y. Chen, et al. 2019. LongShengZhi Capsule reduces established atherosclerotic lesions in apoE-deficient mice by ameliorating hepatic lipid metabolism and inhibiting inflammation. Journal of Cardiovascular Pharmacology 73 (2): 105\u2013117. https:\/\/doi.org\/10.1097\/FJC.0000000000000642.","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"19","key":"1725_CR57","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1093\/eurheartj\/ehab920","volume":"43","author":"A Edsfeldt","year":"2022","unstructured":"Edsfeldt, A., M. Swart, P. Singh, L. Dib, J. Sun, J.E. Cole, I. Park, et al. 2022. Interferon regulatory factor-5-dependent CD11c+ macrophages contribute to the formation of rupture-prone atherosclerotic plaques. European Heart Journal 43 (19): 1864\u20131877. https:\/\/doi.org\/10.1093\/eurheartj\/ehab920.","journal-title":"European Heart Journal"},{"key":"1725_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.843712","volume":"13","author":"H Li","year":"2022","unstructured":"Li, H., Z. Cao, L. Wang, C. Liu, H. Lin, Y. Tang, and P. Yao. 2022. Macrophage subsets and death are responsible for atherosclerotic plaque formation. Frontiers in Immunology 13: 843712. https:\/\/doi.org\/10.3389\/fimmu.2022.843712.","journal-title":"Frontiers in Immunology"},{"key":"1725_CR59","doi-asserted-by":"publisher","unstructured":"Huang, S.U., and K.M. O'Sullivan. 2022. The expanding role of extracellular traps in inflammation and autoimmunity: the new players in casting dark webs. International Journal of Molecular Sciences 23 (7). https:\/\/doi.org\/10.3390\/ijms23073793.","DOI":"10.3390\/ijms23073793"},{"issue":"6","key":"1725_CR60","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1161\/CIRCRESAHA.122.320857","volume":"130","author":"GA Francis","year":"2022","unstructured":"Francis, G.A., and B. Razani. 2022. Autophagy in atherosclerosis: Not all foam cells are created equal. Circulation Research 130 (6): 848\u2013850. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.320857.","journal-title":"Circulation Research"},{"issue":"12","key":"1725_CR61","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1161\/CIRCRESAHA.121.318908","volume":"129","author":"L Qiao","year":"2021","unstructured":"Qiao, L., J. Ma, Z. Zhang, W. Sui, C. Zhai, D. Xu, Z. Wang, et al. 2021. Deficient chaperone-mediated autophagy promotes inflammation and atherosclerosis. Circulation Research 129 (12): 1141\u20131157. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318908.","journal-title":"Circulation Research"},{"issue":"1","key":"1725_CR62","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/ATVBAHA.119.312802","volume":"40","author":"TJ Barrett","year":"2020","unstructured":"Barrett, T.J. 2020. Macrophages in atherosclerosis regression. Arteriosclerosis, Thrombosis, and Vascular Biology 40 (1): 20\u201333. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312802.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"1","key":"1725_CR63","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.imbio.2017.10.005","volume":"223","author":"DA Chistiakov","year":"2018","unstructured":"Chistiakov, D.A., V.A. Myasoedova, V.V. Revin, A.N. Orekhov, and Y.V. Bobryshev. 2018. The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2. Immunobiology 223 (1): 101\u2013111. https:\/\/doi.org\/10.1016\/j.imbio.2017.10.005.","journal-title":"Immunobiology"},{"issue":"1","key":"1725_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12265-020-10049-w","volume":"14","author":"MJM Silvis","year":"2021","unstructured":"Silvis, M.J.M., E.J. Demkes, A.T.L. Fiolet, M. Dekker, L. Bosch, G.P.J. van Hout, L. Timmers, and D.P.V. de Kleijn. 2021. Immunomodulation of the NLRP3 inflammasome in atherosclerosis, coronary artery disease, and acute myocardial infarction. Journal of Cardiovascular Translational Research 14 (1): 23\u201334. https:\/\/doi.org\/10.1007\/s12265-020-10049-w.","journal-title":"Journal of Cardiovascular Translational Research"},{"issue":"9","key":"1725_CR65","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","volume":"126","author":"A Abbate","year":"2020","unstructured":"Abbate, A., S. Toldo, C. Marchetti, J. Kron, B.W. Van Tassell, and C.A. Dinarello. 2020. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease. Circulation Research 126 (9): 1260\u20131280. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.315937.","journal-title":"Circulation Research"},{"key":"1725_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105447","volume":"165","author":"X He","year":"2021","unstructured":"He, X., X. Fan, B. Bai, N. Lu, S. Zhang, and L. Zhang. 2021. Pyroptosis is a critical immune-inflammatory response involved in atherosclerosis. Pharmacological Research 165: 105447. https:\/\/doi.org\/10.1016\/j.phrs.2021.105447.","journal-title":"Pharmacological Research"},{"issue":"4","key":"1725_CR67","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.iac.2021.07.003","volume":"41","author":"BP Kaur","year":"2021","unstructured":"Kaur, B.P., and E. Secord. 2021. Innate Immunity. Immunology and Allergy Clinics of North America 41 (4): 535\u2013541. https:\/\/doi.org\/10.1016\/j.iac.2021.07.003.","journal-title":"Immunology and Allergy Clinics of North America"},{"key":"1725_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2019.02.002","volume":"59","author":"T Taguchi","year":"2019","unstructured":"Taguchi, T., and K. Mukai. 2019. Innate immunity signalling and membrane trafficking. Current Opinion in Cell Biology 59: 1\u20137. https:\/\/doi.org\/10.1016\/j.ceb.2019.02.002.","journal-title":"Current Opinion in Cell Biology"},{"key":"1725_CR69","doi-asserted-by":"publisher","unstructured":"Sokol, C.L., and A.D. Luster. 2015. The chemokine system in innate immunity. Cold Spring Harbor Perspectives in Biology\u00a07 (5). https:\/\/doi.org\/10.1101\/cshperspect.a016303.","DOI":"10.1101\/cshperspect.a016303"},{"key":"1725_CR70","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-immunol-093019-123619","volume":"39","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q., and X. Cao. 2021. Epigenetic remodeling in innate immunity and inflammation. Annual Review of Immunology 39: 279\u2013311. https:\/\/doi.org\/10.1146\/annurev-immunol-093019-123619.","journal-title":"Annual Review of Immunology"},{"issue":"2","key":"1725_CR71","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s12015-021-10138-6","volume":"17","author":"MZ Ratajczak","year":"2021","unstructured":"Ratajczak, M.Z., and J. Ratajczak. 2021. Innate Immunity Communicates Using the Language of Extracellular Microvesicles. Stem Cell Reviews and Reports 17 (2): 502\u2013510. https:\/\/doi.org\/10.1007\/s12015-021-10138-6.","journal-title":"Stem Cell Reviews and Reports"},{"issue":"8","key":"1725_CR72","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1002\/jcp.30285","volume":"236","author":"Z Yan","year":"2021","unstructured":"Yan, Z., Z. Qi, X. Yang, N. Ji, Y. Wang, Q. Shi, M. Li, J. Zhang, and Y. Zhu. 2021. The NLRP3 inflammasome: Multiple activation pathways and its role in primary cells during ventricular remodeling. Journal of Cellular Physiology 236 (8): 5547\u20135563. https:\/\/doi.org\/10.1002\/jcp.30285.","journal-title":"Journal of Cellular Physiology"},{"issue":"4","key":"1725_CR73","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.arr.2013.09.004","volume":"12","author":"DY Fann","year":"2013","unstructured":"Fann, D.Y., S.Y. Lee, S. Manzanero, P. Chunduri, C.G. Sobey, and T.V. Arumugam. 2013. Pathogenesis of acute stroke and the role of inflammasomes. Ageing Research Reviews 12 (4): 941\u2013966. https:\/\/doi.org\/10.1016\/j.arr.2013.09.004.","journal-title":"Ageing Research Reviews"},{"issue":"9","key":"1725_CR74","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Y Huang","year":"2021","unstructured":"Huang, Y., W. Xu, and R. Zhou. 2021. NLRP3 inflammasome activation and cell death. Cellular & Molecular Immunology 18 (9): 2114\u20132127. https:\/\/doi.org\/10.1038\/s41423-021-00740-6.","journal-title":"Cellular & Molecular Immunology"},{"issue":"5","key":"1725_CR75","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","volume":"18","author":"S Paik","year":"2021","unstructured":"Paik, S., J.K. Kim, P. Silwal, C. Sasakawa, and E.K. Jo. 2021. An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cellular & Molecular Immunology 18 (5): 1141\u20131160. https:\/\/doi.org\/10.1038\/s41423-021-00670-3.","journal-title":"Cellular & Molecular Immunology"},{"key":"1725_CR76","doi-asserted-by":"publisher","unstructured":"Mezzaroma, E., A. Abbate, and S. Toldo. 2021. NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases. Molecules 26 (4). https:\/\/doi.org\/10.3390\/molecules26040976.","DOI":"10.3390\/molecules26040976"},{"key":"1725_CR77","doi-asserted-by":"publisher","unstructured":"Liu, B., and J. Yu. 2021. Anti-NLRP3 Inflammasome Natural Compounds: An Update. Biomedicines 9 (2). https:\/\/doi.org\/10.3390\/biomedicines9020136.","DOI":"10.3390\/biomedicines9020136"},{"key":"1725_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108053","volume":"236","author":"S Toldo","year":"2021","unstructured":"Toldo, S., E. Mezzaroma, L.F. Buckley, N. Potere, M. Di Nisio, G. Biondi-Zoccai, B.W. Van Tassell, and A. Abbate. 2021. Targeting the NLRP3 inflammasome in cardiovascular diseases. Pharmacology & Therapeutics 236: 108053. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108053.","journal-title":"Pharmacology & Therapeutics"},{"key":"1725_CR79","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fphar.2015.00262","volume":"6","author":"BZ Shao","year":"2015","unstructured":"Shao, B.Z., Z.Q. Xu, B.Z. Han, D.F. Su, and C. Liu. 2015. NLRP3 inflammasome and its inhibitors: A review. Frontiers in Pharmacology 6: 262. https:\/\/doi.org\/10.3389\/fphar.2015.00262.","journal-title":"Frontiers in Pharmacology"},{"key":"1725_CR80","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","volume":"10","author":"A Zahid","year":"2019","unstructured":"Zahid, A., B. Li, A.J.K. Kombe, T. Jin, and J. Tao. 2019. Pharmacological Inhibitors of the NLRP3 Inflammasome. Frontiers in Immunology 10: 2538. https:\/\/doi.org\/10.3389\/fimmu.2019.02538.","journal-title":"Frontiers in Immunology"},{"key":"1725_CR81","doi-asserted-by":"publisher","unstructured":"Seoane, P.I., B. Lee, C. Hoyle, S. Yu, G. Lopez-Castejon, M. Lowe, and D. Brough. 2020. The NLRP3-inflammasome as a sensor of organelle dysfunction. Journal of Cell Biology\u00a0219 (12). https:\/\/doi.org\/10.1083\/jcb.202006194.","DOI":"10.1083\/jcb.202006194"},{"issue":"2","key":"1725_CR82","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","volume":"10","author":"Y Yang","year":"2019","unstructured":"Yang, Y., H. Wang, M. Kouadir, H. Song, and F. Shi. 2019. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death & Disease 10 (2): 128. https:\/\/doi.org\/10.1038\/s41419-019-1413-8.","journal-title":"Cell Death & Disease"},{"key":"1725_CR83","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fimmu.2020.00211","volume":"11","author":"C Zhao","year":"2020","unstructured":"Zhao, C., and W. Zhao. 2020. NLRP3 Inflammasome-A Key Player in Antiviral Responses. Frontiers in Immunology 11: 211. https:\/\/doi.org\/10.3389\/fimmu.2020.00211.","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"1725_CR84","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"EK Jo","year":"2016","unstructured":"Jo, E.K., J.K. Kim, D.M. Shin, and C. Sasakawa. 2016. Molecular mechanisms regulating NLRP3 inflammasome activation. Cellular & Molecular Immunology 13 (2): 148\u2013159. https:\/\/doi.org\/10.1038\/cmi.2015.95.","journal-title":"Cellular & Molecular Immunology"},{"key":"1725_CR85","doi-asserted-by":"publisher","unstructured":"El-Sharkawy, L.Y., D. Brough, and S. Freeman. 2020. Inhibiting the NLRP3 Inflammasome. Molecules 25 (23). https:\/\/doi.org\/10.3390\/molecules25235533.","DOI":"10.3390\/molecules25235533"},{"key":"1725_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100889","volume":"76","author":"L Wang","year":"2020","unstructured":"Wang, L., and A.V. Hauenstein. 2020. The NLRP3 inflammasome: Mechanism of action, role in disease and therapies. Molecular Aspects of Medicine 76: 100889. https:\/\/doi.org\/10.1016\/j.mam.2020.100889.","journal-title":"Molecular Aspects of Medicine"},{"key":"1725_CR87","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3389\/fimmu.2020.01444","volume":"11","author":"S Hamarsheh","year":"2020","unstructured":"Hamarsheh, S., and R. Zeiser. 2020. NLRP3 inflammasome activation in cancer: A double-edged sword. Frontiers in Immunology 11: 1444. https:\/\/doi.org\/10.3389\/fimmu.2020.01444.","journal-title":"Frontiers in Immunology"},{"key":"1725_CR88","doi-asserted-by":"crossref","unstructured":"Walsh, GM. 2009. Canakinumab for the treatment of cryopyrin-associated periodic syndromes. Drugs Today (Barc) 45 (10):731-735. https:\/\/doi.org\/1396674\/dot.2009.45.10.1416583","DOI":"10.1358\/dot.2009.45.10.1436882"},{"issue":"6","key":"1725_CR89","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1586\/eci.10.66","volume":"6","author":"LD Church","year":"2010","unstructured":"Church, L.D., and M.F. McDermott. 2010. Canakinumab: A human anti-IL-1beta monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes. Expert Review of Clinical Immunology 6 (6): 831\u2013841. https:\/\/doi.org\/10.1586\/eci.10.66.","journal-title":"Expert Review of Clinical Immunology"},{"issue":"4","key":"1725_CR90","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00281-015-0491-7","volume":"37","author":"JB Kuemmerle-Deschner","year":"2015","unstructured":"Kuemmerle-Deschner, J.B. 2015. CAPS\u2013pathogenesis, presentation and treatment of an autoinflammatory disease. Semin Immunopathol 37 (4): 377\u2013385. https:\/\/doi.org\/10.1007\/s00281-015-0491-7.","journal-title":"Semin Immunopathol"},{"key":"1725_CR91","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fneur.2020.00141","volume":"11","author":"H Nakanishi","year":"2020","unstructured":"Nakanishi, H., P. Prakash, T. Ito, H.J. Kim, C.C. Brewer, D. Harrow, I. Roux, S. Hosokawa, and A.J. Griffith. 2020. Genetic hearing loss associated with autoinflammation. Frontiers in Neurology 11: 141. https:\/\/doi.org\/10.3389\/fneur.2020.00141.","journal-title":"Frontiers in Neurology"},{"issue":"9","key":"1725_CR92","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci, L., and E. Fabbri. 2018. Inflammageing: Chronic inflammation in ageing, cardiovascular disease, and frailty. Nature Reviews. Cardiology 15 (9): 505\u2013522. https:\/\/doi.org\/10.1038\/s41569-018-0064-2.","journal-title":"Nature Reviews. Cardiology"},{"issue":"4","key":"1725_CR93","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","volume":"162","author":"PM Ridker","year":"2011","unstructured":"Ridker, P.M., T. Thuren, A. Zalewski, and P. Libby. 2011. Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: Rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). American Heart Journal 162 (4): 597\u2013605. https:\/\/doi.org\/10.1016\/j.ahj.2011.06.012.","journal-title":"American Heart Journal"},{"issue":"13","key":"1725_CR94","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1089\/ars.2014.5978","volume":"22","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y., X. Li, A.L. Pitzer, Y. Chen, L. Wang, and P.L. Li. 2015. Coronary endothelial dysfunction induced by nucleotide oligomerization domain-like receptor protein with pyrin domain containing 3 inflammasome activation during hypercholesterolemia: Beyond inflammation. Antioxidants & Redox Signaling 22 (13): 1084\u20131096. https:\/\/doi.org\/10.1089\/ars.2014.5978.","journal-title":"Antioxidants & Redox Signaling"},{"issue":"7","key":"1725_CR95","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/eji.201041316","volume":"41","author":"S Freigang","year":"2011","unstructured":"Freigang, S., F. Ampenberger, G. Spohn, S. Heer, A.T. Shamshiev, J. Kisielow, M. Hersberger, M. Yamamoto, M.F. Bachmann, and M. Kopf. 2011. Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis. European Journal of Immunology 41 (7): 2040\u20132051. https:\/\/doi.org\/10.1002\/eji.201041316.","journal-title":"European Journal of Immunology"},{"issue":"7","key":"1725_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011765","volume":"5","author":"K Rajamaki","year":"2010","unstructured":"Rajamaki, K., J. Lappalainen, K. Oorni, E. Valimaki, S. Matikainen, P.T. Kovanen, and K.K. Eklund. 2010. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: A novel link between cholesterol metabolism and inflammation. PLoS ONE 5 (7): e11765. https:\/\/doi.org\/10.1371\/journal.pone.0011765.","journal-title":"PLoS ONE"},{"issue":"3","key":"1725_CR97","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/jcp.25930","volume":"233","author":"Z Hoseini","year":"2018","unstructured":"Hoseini, Z., F. Sepahvand, B. Rashidi, A. Sahebkar, A. Masoudifar, and H. Mirzaei. 2018. NLRP3 inflammasome: Its regulation and involvement in atherosclerosis. Journal of Cellular Physiology 233 (3): 2116\u20132132. https:\/\/doi.org\/10.1002\/jcp.25930.","journal-title":"Journal of Cellular Physiology"},{"issue":"5","key":"1725_CR98","doi-asserted-by":"publisher","first-page":"443","DOI":"10.5551\/jat.RV17001","volume":"24","author":"T Karasawa","year":"2017","unstructured":"Karasawa, T., and M. Takahashi. 2017. Role of NLRP3 Inflammasomes in Atherosclerosis. Journal of Atherosclerosis and Thrombosis 24 (5): 443\u2013451. https:\/\/doi.org\/10.5551\/jat.RV17001.","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"issue":"3","key":"1725_CR99","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/ATVBAHA.119.313224","volume":"40","author":"Y Kimura","year":"2020","unstructured":"Kimura, Y., T. Yanagida, A. Onda, D. Tsukui, M. Hosoyamada, and H. Kono. 2020. Soluble Uric Acid Promotes Atherosclerosis via AMPK (AMP-Activated Protein Kinase)-Mediated Inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology 40 (3): 570\u2013582. https:\/\/doi.org\/10.1161\/ATVBAHA.119.313224.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"2","key":"1725_CR100","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10753-019-01106-x","volume":"43","author":"SS Xing","year":"2020","unstructured":"Xing, S.S., J. Yang, W.J. Li, J. Li, L. Chen, Y.T. Yang, X. Lei, J. Li, K. Wang, and X. Liu. 2020. Salidroside decreases atherosclerosis plaque formation via inhibiting endothelial cell pyroptosis. Inflammation 43 (2): 433\u2013440. https:\/\/doi.org\/10.1007\/s10753-019-01106-x.","journal-title":"Inflammation"},{"key":"1725_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109843","volume":"78","author":"H Jin","year":"2021","unstructured":"Jin, H., Y. Zhu, X.D. Wang, E.F. Luo, Y.P. Li, B.L. Wang, and Y.F. Chen. 2021. BDNF corrects NLRP3 inflammasome-induced pyroptosis and glucose metabolism reprogramming through KLF2\/HK1 pathway in vascular endothelial cells. Cellular Signalling 78: 109843. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109843.","journal-title":"Cellular Signalling"},{"issue":"5","key":"1725_CR102","doi-asserted-by":"publisher","first-page":"950","DOI":"10.5114\/aoms.2016.61356","volume":"12","author":"WL Li","year":"2016","unstructured":"Li, W.L., L.G. Hua, P. Qu, W.H. Yan, C. Ming, Y.D. Jun, L.D. Yuan, and N. Nan. 2016. NLRP3 inflammasome: A novel link between lipoproteins and atherosclerosis. Archives of Medical Science 12 (5): 950\u2013958. https:\/\/doi.org\/10.5114\/aoms.2016.61356.","journal-title":"Archives of Medical Science"},{"issue":"2","key":"1725_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112108","volume":"393","author":"Z Zeng","year":"2020","unstructured":"Zeng, Z., Q. Zheng, J. Chen, X. Tan, Q. Li, L. Ding, R. Zhang, and X. Lin. 2020. FGF21 mitigates atherosclerosis via inhibition of NLRP3 inflammasome-mediated vascular endothelial cells pyroptosis. Experimental Cell Research 393 (2): 112108. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112108.","journal-title":"Experimental Cell Research"},{"key":"1725_CR104","doi-asserted-by":"publisher","unstructured":"Dintcheva, N.T., G. Infurna, M. Baiamonte, and F. D'Anna. 2020. Natural compounds as sustainable additives for biopolymers. Polymers (Basel) 12 (4). https:\/\/doi.org\/10.3390\/polym12040732.","DOI":"10.3390\/polym12040732"},{"issue":"16","key":"1725_CR105","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.2174\/1389450119666180514120438","volume":"19","author":"A Woodbury","year":"2018","unstructured":"Woodbury, A., M.R. McCrary, and S.P. Yu. 2018. Molecular targets and natural compounds in drug development for the treatment of inflammatory pain. Current Drug Targets 19 (16): 1905\u20131915. https:\/\/doi.org\/10.2174\/1389450119666180514120438.","journal-title":"Current Drug Targets"},{"key":"1725_CR106","doi-asserted-by":"publisher","unstructured":"Zhang, S., R. Zhong, S. Tang, H. Han, L. Chen, and H. Zhang. 2022. Baicalin alleviates short-term lincomycin-induced intestinal and liver injury and inflammation in infant mice. International Journal of Molecular Sciences 23 (11). https:\/\/doi.org\/10.3390\/ijms23116072.","DOI":"10.3390\/ijms23116072"},{"issue":"1","key":"1725_CR107","doi-asserted-by":"publisher","first-page":"14","DOI":"10.22038\/IJBMS.2022.60380.13381","volume":"25","author":"Z Hu","year":"2022","unstructured":"Hu, Z., Y. Guan, W. Hu, Z. Xu, and M. Ishfaq. 2022. An overview of pharmacological activities of baicalin and its aglycone baicalein: New insights into molecular mechanisms and signaling pathways. Iranian Journal of Basic Medical Sciences 25 (1): 14\u201326. https:\/\/doi.org\/10.22038\/IJBMS.2022.60380.13381.","journal-title":"Iranian Journal of Basic Medical Sciences"},{"issue":"6","key":"1725_CR108","doi-asserted-by":"publisher","first-page":"147916412097744","DOI":"10.1177\/1479164120977441","volume":"17","author":"J Zhao","year":"2020","unstructured":"Zhao, J., Z. Wang, Z. Yuan, S. Lv, and Q. Su. 2020. Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice. Diabetes & Vascular Disease Research 17 (6): 1479164120977441. https:\/\/doi.org\/10.1177\/1479164120977441.","journal-title":"Diabetes & Vascular Disease Research"},{"key":"1725_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.794563","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun, Y., S. Liu, S. Yang, C. Chen, Y. Yang, M. Lin, C. Liu, et al. 2021. Mechanism of dihydromyricetin on inflammatory diseases. Frontiers in Pharmacology 12: 794563. https:\/\/doi.org\/10.3389\/fphar.2021.794563.","journal-title":"Frontiers in Pharmacology"},{"key":"1725_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112771","volume":"148","author":"Y Wang","year":"2022","unstructured":"Wang, Y., J. Wang, H. Xiang, P. Ding, T. Wu, and G. Ji. 2022. Recent update on application of dihydromyricetin in metabolic related diseases. Biomedicine & Pharmacotherapy 148: 112771. https:\/\/doi.org\/10.1016\/j.biopha.2022.112771.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"1725_CR111","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/biof.1395","volume":"44","author":"Q Hu","year":"2018","unstructured":"Hu, Q., T. Zhang, L. Yi, X. Zhou, and M. Mi. 2018. Dihydromyricetin inhibits NLRP3 inflammasome-dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cells. BioFactors 44 (2): 123\u2013136. https:\/\/doi.org\/10.1002\/biof.1395.","journal-title":"BioFactors"},{"key":"1725_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2022.06.003","author":"X Ge","year":"2022","unstructured":"Ge, X., X. He, J. Liu, F. Zeng, L. Chen, W. Xu, R. Shao, et al. 2022. Amelioration of type 2 diabetes by the novel 6, 8-guanidyl luteolin quinone-chromium coordination via biochemical mechanisms and gut microbiota interaction. Journal of Advanced Research. https:\/\/doi.org\/10.1016\/j.jare.2022.06.003.","journal-title":"Journal of Advanced Research"},{"key":"1725_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113121","volume":"151","author":"H Wang","year":"2022","unstructured":"Wang, H., X. Yao, K. Huang, J. Zhang, J. Xiao, J. Guo, D. Wei, and B. Xiang. 2022. Low-dose dexamethasone in combination with luteolin improves myocardial infarction recovery by activating the antioxidative response. Biomedicine & Pharmacotherapy 151: 113121. https:\/\/doi.org\/10.1016\/j.biopha.2022.113121.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"1725_CR114","doi-asserted-by":"crossref","unstructured":"Zhang, B.C., Z. Li, W. Xu, C.H. Xiang, and Y.F. Ma. 2018. Luteolin alleviates NLRP3 inflammasome activation and directs macrophage polarization in lipopolysaccharide-stimulated RAW264.7 cells.\u00a0American Journal of Translational Research\u00a010 (1):265\u2013273.","DOI":"10.1007\/s10753-018-0891-7"},{"issue":"1","key":"1725_CR115","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1096\/fj.201900903RRR","volume":"34","author":"J Luo","year":"2020","unstructured":"Luo, J., X. Wang, X. Jiang, C. Liu, Y. Li, X. Han, X. Zuo, et al. 2020. Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport. The FASEB Journal 34 (1): 1398\u20131411. https:\/\/doi.org\/10.1096\/fj.201900903RRR.","journal-title":"The FASEB Journal"},{"key":"1725_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.804899","volume":"9","author":"F Zhou","year":"2022","unstructured":"Zhou, F., L. Yao, X. Lu, Y. Li, X. Han, and P. Wang. 2022. Therapeutic targeting of GSK3beta-regulated Nrf2 and NFkappaB signaling pathways by salvianolic acid a ameliorates peritoneal fibrosis. Front Med (Lausanne) 9: 804899. https:\/\/doi.org\/10.3389\/fmed.2022.804899.","journal-title":"Front Med (Lausanne)"},{"key":"1725_CR117","doi-asserted-by":"publisher","unstructured":"Li, S., R. Wang, F. Song, P. Chen, Y. Gu, C. Chen, and Y. Yuan. 2022. Salvianolic acid A suppresses CCl4-induced liver fibrosis through regulating the Nrf2\/HO-1, NF-kappaB\/IkappaBalpha, p38 MAPK, and JAK1\/STAT3 signaling pathways. Drug and Chemical Toxicology\u00a0pp 1\u201310. https:\/\/doi.org\/10.1080\/01480545.2022.2028822.","DOI":"10.1080\/01480545.2022.2028822"},{"key":"1725_CR118","doi-asserted-by":"publisher","unstructured":"Ma, Q., Q. Yang, J. Chen, C. Yu, L. Zhang, W. Zhou, and M. Chen. 2020. Salvianolic acid a ameliorates early-stage atherosclerosis development by inhibiting NLRP3 inflammasome activation in Zucker diabetic fatty rats. Molecules 25 (5). https:\/\/doi.org\/10.3390\/molecules25051089.","DOI":"10.3390\/molecules25051089"},{"issue":"1","key":"1725_CR119","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0034-1397344","volume":"35","author":"AM Mohr","year":"2015","unstructured":"Mohr, A.M., and J.L. Mott. 2015. Overview of microRNA biology. Seminars in Liver Disease 35 (1): 3\u201311. https:\/\/doi.org\/10.1055\/s-0034-1397344.","journal-title":"Seminars in Liver Disease"},{"issue":"4","key":"1725_CR120","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu, T.X., and M.E. Rothenberg. 2018. MicroRNA. The Journal of Allergy and Clinical Immunology 141 (4): 1202\u20131207. https:\/\/doi.org\/10.1016\/j.jaci.2017.08.034.","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"1725_CR121","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1631\/jzus.B1500267","volume":"17","author":"B Xu","year":"2016","unstructured":"Xu, B., Y.Y. Li, J. Ma, and F.X. Pei. 2016. Roles of microRNA and signaling pathway in osteoarthritis pathogenesis. Journal of Zhejiang University. Science. B 17 (3): 200\u2013208. https:\/\/doi.org\/10.1631\/jzus.B1500267.","journal-title":"Journal of Zhejiang University. Science. B"},{"issue":"8","key":"1725_CR122","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1039\/c4ob02104e","volume":"13","author":"T Tian","year":"2015","unstructured":"Tian, T., J. Wang, and X. Zhou. 2015. A review: MicroRNA detection methods. Organic & Biomolecular Chemistry 13 (8): 2226\u20132238. https:\/\/doi.org\/10.1039\/c4ob02104e.","journal-title":"Organic & Biomolecular Chemistry"},{"issue":"4","key":"1725_CR123","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1016\/j.bbrc.2018.08.049","volume":"503","author":"P Li","year":"2018","unstructured":"Li, P., X. Zhong, J. Li, H. Liu, X. Ma, R. He, and Y. Zhao. 2018. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis. Biochemical and Biophysical Research Communications 503 (4): 2833\u20132840. https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.049.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"1725_CR124","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1159\/000470822","volume":"41","author":"Y Wang","year":"2017","unstructured":"Wang, Y., Z. Han, Y. Fan, J. Zhang, K. Chen, L. Gao, H. Zeng, J. Cao, and C. Wang. 2017. MicroRNA-9 Inhibits NLRP3 Inflammasome Activation in Human Atherosclerosis Inflammation Cell Models through the JAK1\/STAT Signaling Pathway. Cellular Physiology and Biochemistry 41 (4): 1555\u20131571. https:\/\/doi.org\/10.1159\/000470822.","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"18","key":"1725_CR125","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.21037\/atm-21-3903","volume":"9","author":"J Hou","year":"2021","unstructured":"Hou, J., Q. Deng, X. Deng, W. Zhong, S. Liu, and Z. Zhong. 2021. MicroRNA-146a-5p alleviates lipopolysaccharide-induced NLRP3 inflammasome injury and pro-inflammatory cytokine production via the regulation of TRAF6 and IRAK1 in human umbilical vein endothelial cells (HUVECs). Annals of Translational Medicine 9 (18): 1433. https:\/\/doi.org\/10.21037\/atm-21-3903.","journal-title":"Annals of Translational Medicine"},{"issue":"20","key":"1725_CR126","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.21037\/atm-21-4939","volume":"9","author":"B Li","year":"2021","unstructured":"Li, B., Z. Zhang, and Y. Fu. 2021. Anti-inflammatory effects of artesunate on atherosclerosis via miR-16-5p and TXNIP regulation of the NLRP3 inflammasome. Annals of Translational Medicine 9 (20): 1558. https:\/\/doi.org\/10.21037\/atm-21-4939.","journal-title":"Annals of Translational Medicine"},{"issue":"8","key":"1725_CR127","doi-asserted-by":"publisher","first-page":"13640","DOI":"10.1002\/jcb.28637","volume":"120","author":"J Song","year":"2019","unstructured":"Song, J., S. Yang, R. Yin, Q. Xiao, A. Ma, and X. Pan. 2019. MicroRNA-181a regulates the activation of the NLRP3 inflammatory pathway by targeting MEK1 in THP-1 macrophages stimulated by ox-LDL. Journal of Cellular Biochemistry 120 (8): 13640\u201313650. https:\/\/doi.org\/10.1002\/jcb.28637.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"1","key":"1725_CR128","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.2697","volume":"221","author":"D Glick","year":"2010","unstructured":"Glick, D., S. Barth, and K.F. Macleod. 2010. Autophagy: Cellular and molecular mechanisms. The Journal of Pathology 221 (1): 3\u201312. https:\/\/doi.org\/10.1002\/path.2697.","journal-title":"The Journal of Pathology"},{"issue":"1\u20132","key":"1725_CR129","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","volume":"176","author":"B Levine","year":"2019","unstructured":"Levine, B., and G. Kroemer. 2019. Biological Functions of Autophagy Genes: A Disease Perspective. Cell 176 (1\u20132): 11\u201342. https:\/\/doi.org\/10.1016\/j.cell.2018.09.048.","journal-title":"Cell"},{"issue":"19","key":"1725_CR130","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108863","volume":"40","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky, D.J., G. Petroni, R.K. Amaravadi, E.H. Baehrecke, A. Ballabio, P. Boya, J.M. Bravo-San Pedro, et al. 2021. Autophagy in major human diseases. EMBO Journal 40 (19): e108863. https:\/\/doi.org\/10.15252\/embj.2021108863.","journal-title":"EMBO Journal"},{"issue":"3","key":"1725_CR131","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1089\/ars.2013.5371","volume":"20","author":"KR Parzych","year":"2014","unstructured":"Parzych, K.R., and D.J. Klionsky. 2014. An overview of autophagy: Morphology, mechanism, and regulation. Antioxidants & Redox Signaling 20 (3): 460\u2013473. https:\/\/doi.org\/10.1089\/ars.2013.5371.","journal-title":"Antioxidants & Redox Signaling"},{"issue":"4","key":"1725_CR132","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/2047487319869400","volume":"27","author":"K Lechner","year":"2020","unstructured":"Lechner, K., C. von Schacky, A.L. McKenzie, N. Worm, U. Nixdorff, B. Lechner, N. Krankel, M. Halle, R.M. Krauss, and J. Scherr. 2020. Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors. European Journal of Preventive Cardiology 27 (4): 394\u2013406. https:\/\/doi.org\/10.1177\/2047487319869400.","journal-title":"European Journal of Preventive Cardiology"},{"key":"1725_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.739882","volume":"13","author":"L Zhu","year":"2022","unstructured":"Zhu, L., and L. Liu. 2022. New Insights Into the Interplay Among Autophagy, the NLRP3 Inflammasome and Inflammation in Adipose Tissue. Front Endocrinol (Lausanne) 13: 739882. https:\/\/doi.org\/10.3389\/fendo.2022.739882.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1725_CR134","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cmet.2012.02.011","volume":"15","author":"B Razani","year":"2012","unstructured":"Razani, B., C. Feng, T. Coleman, R. Emanuel, H. Wen, S. Hwang, J.P. Ting, H.W. Virgin, M.B. Kastan, and C.F. Semenkovich. 2012. Autophagy links inflammasomes to atherosclerotic progression. Cell Metabolism 15 (4): 534\u2013544. https:\/\/doi.org\/10.1016\/j.cmet.2012.02.011.","journal-title":"Cell Metabolism"},{"key":"1725_CR135","doi-asserted-by":"publisher","first-page":"9286458","DOI":"10.1155\/2018\/9286458","volume":"2018","author":"S Ma","year":"2018","unstructured":"Ma, S., J. Chen, J. Feng, R. Zhang, M. Fan, D. Han, X. Li, et al. 2018. Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition. Oxidative Medicine and Cellular Longevity 2018: 9286458. https:\/\/doi.org\/10.1155\/2018\/9286458.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"9","key":"1725_CR136","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1194\/jlr.M075879","volume":"58","author":"L Shen","year":"2017","unstructured":"Shen, L., Y. Yang, T. Ou, C.C. Key, S.H. Tong, R.C. Sequeira, J.M. Nelson, et al. 2017. Dietary PUFAs attenuate NLRP3 inflammasome activation via enhancing macrophage autophagy. Journal of Lipid Research 58 (9): 1808\u20131821. https:\/\/doi.org\/10.1194\/jlr.M075879.","journal-title":"Journal of Lipid Research"},{"key":"1725_CR137","doi-asserted-by":"publisher","unstructured":"Abderrazak, A., D. Couchie, D.F. Mahmood, R. Elhage, C. Vindis, M. Laffargue, V. Mateo, et al.\u00a02015. Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in ApoE2.Ki mice fed a high-fat diet. Circulation 131 (12):1061\u20131070. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.013730.","DOI":"10.1161\/CIRCULATIONAHA.114.013730"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-022-01725-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-022-01725-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-022-01725-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T06:12:10Z","timestamp":1677478330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-022-01725-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":137,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1725"],"URL":"https:\/\/doi.org\/10.1007\/s10753-022-01725-x","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]},"assertion":[{"value":"18 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DECLARATIONS"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"This paper has got consent for publication from all authors listed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}